Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $9.38 billion. The enterprise value is $9.11 billion.
| Market Cap | 9.38B |
| Enterprise Value | 9.11B |
Important Dates
The next confirmed earnings date is Wednesday, April 24, 2024, after market close.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | Feb 23, 2024 |
Share Statistics
Chemed has 15.14 million shares outstanding. The number of shares has increased by 0.67% in one year.
| Shares Outstanding | 15.14M |
| Shares Change (YoY) | +0.67% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 2.39% |
| Owned by Institutions (%) | 96.81% |
| Float | 14.83M |
Valuation Ratios
The trailing PE ratio is 34.41 and the forward PE ratio is 25.97. Chemed's PEG ratio is 2.63.
| PE Ratio | 34.41 |
| Forward PE | 25.97 |
| PS Ratio | 4.12 |
| Forward PS | 3.82 |
| PB Ratio | 8.43 |
| P/FCF Ratio | 34.07 |
| PEG Ratio | 2.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.99, with an EV/FCF ratio of 33.24.
| EV / Earnings | 33.44 |
| EV / Sales | 4.02 |
| EV / EBITDA | 21.99 |
| EV / EBIT | 25.78 |
| EV / FCF | 33.24 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.61 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.09 |
| Debt / FCF | 0.14 |
| Interest Coverage | 113.73 |
Financial Efficiency
Return on equity (ROE) is 27.50% and return on invested capital (ROIC) is 23.10%.
| Return on Equity (ROE) | 27.50% |
| Return on Assets (ROA) | 17.70% |
| Return on Capital (ROIC) | 23.10% |
| Revenue Per Employee | $150,091 |
| Profits Per Employee | $18,063 |
| Employee Count | 15,087 |
| Asset Turnover | 1.47 |
| Inventory Turnover | 131.59 |
Taxes
In the past 12 months, Chemed has paid $77.86 million in taxes.
| Income Tax | 77.86M |
| Effective Tax Rate | 22.22% |
Stock Price Statistics
The stock price has increased by +8.69% in the last 52 weeks. The beta is 0.42, so Chemed's price volatility has been lower than the market average.
| Beta (1Y) | 0.42 |
| 52-Week Price Change | +8.69% |
| 50-Day Moving Average | 622.01 |
| 200-Day Moving Average | 567.28 |
| Relative Strength Index (RSI) | 47.07 |
| Average Volume (30 Days) | 80,195 |
Short Selling Information
The latest short interest is 451,553, so 2.98% of the outstanding shares have been sold short.
| Short Interest | 451,553 |
| Short Previous Month | 464,435 |
| Short % of Shares Out | 2.98% |
| Short % of Float | 3.04% |
| Short Ratio (days to cover) | 5.34 |
Income Statement
In the last 12 months, Chemed had revenue of $2.26 billion and earned $272.51 million in profits. Earnings per share was $17.93.
| Revenue | 2.26B |
| Gross Profit | 798.82M |
| Operating Income | 340.57M |
| Pretax Income | 350.37M |
| Net Income | 272.51M |
| EBITDA | 414.34M |
| EBIT | 353.48M |
| Earnings Per Share (EPS) | $17.93 |
Balance Sheet
The company has $263.96 million in cash and $38.64 million in debt, giving a net cash position of $225.32 million or $14.89 per share.
| Cash & Cash Equivalents | 263.96M |
| Total Debt | 38.64M |
| Net Cash | 225.32M |
| Net Cash Per Share | $14.89 |
| Equity / Book Value | 1.11B |
| Book Value Per Share | 73.19 |
| Working Capital | 188.79M |
Cash Flow
In the last 12 months, operating cash flow was $330.30 million and capital expenditures -$56.21 million, giving a free cash flow of $274.09 million.
| Operating Cash Flow | 330.30M |
| Capital Expenditures | -56.21M |
| Free Cash Flow | 274.09M |
| FCF Per Share | $18.21 |
Margins
Gross margin is 35.28%, with operating and profit margins of 15.04% and 12.03%.
| Gross Margin | 35.28% |
| Operating Margin | 15.04% |
| Pretax Margin | 15.47% |
| Profit Margin | 12.03% |
| EBITDA Margin | 18.30% |
| EBIT Margin | 15.61% |
| FCF Margin | 12.10% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | 5.33% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 8.92% |
| Buyback Yield | -0.67% |
| Shareholder Yield | -0.41% |
| Earnings Yield | 2.92% |
| FCF Yield | 2.94% |
Analyst Forecast
The average price target for Chemed is $681.00, which is 9.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $681.00 |
| Price Target Difference | 9.98% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 14.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 14.25 |
| Piotroski F-Score | 5 |